Vanguard Group Inc ownership in NG9 / NeoGenomics, Inc.

NeoGenomics, Inc.

DE ˙ DB ˙ US64049M2098

9,61 € ↑0,99 (11,51%)

2026-06-05
CENA AKCJI

Security	DE:NG9 / NeoGenomics, Inc.
Institution	Vanguard Group Inc
Latest Disclosed Ownership	0 shares
Ownership	0.00%

2026-03-27 - Vanguard Group Inc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of NeoGenomics, Inc. (DE:NG9). This represents 0.0 percent ownership of the company. In their previous filing dated 2024-02-13 , Vanguard Group Inc had reported owning 14,169,665 shares, indicating a decrease of -100.00 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File Date	Effective Date	Form	Prev Shares	Latest Shares	ΔShares (Percent)	Ownership (Percent)	ΔOwnership (Percent)
2026-03-27	2026-03-27	13G/A	14,169,665	0	-100.00	0.00	-100.00
2024-02-13	2024-02-13	13G/A	13,674,745	14,169,665	3.62	11.12	2.68
2023-02-09	2023-02-09	13G/A	12,856,969	13,674,745	6.36	10.83	3.74
2022-02-10	2022-02-10	13G/A	11,167,578	12,856,969	15.13	10.44	3.78
2021-02-10	2021-02-10	13G/A	10,513,003	11,167,578	6.23	10.06	0.00
2020-02-12	2020-02-12	13G/A	10,431,825	10,513,003	0.78	10.06	0.20
2019-10-10	2019-10-10	13G		10,431,825		10.04

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-01-29	2025-12-31	13F	NEOGENOMICS	COM NEW	64049M209	13,828,355	-75,380	-0.54	162,621	51.51	0.0024
2025-11-07	2025-09-30	13F	NEOGENOMICS	COM NEW	64049M209	13,903,735	-227,026	-1.61	107,337	3.91	0.0016
2025-08-11	2025-06-30	13F	NEOGENOMICS	COM NEW	64049M209	14,130,761	-126,355	-0.89	103,296	-23.65	0.0017
2025-05-09	2025-03-31	13F	NEOGENOMICS	COM NEW	64049M209	14,257,116	17,229	0.12	135,300	-42.35	0.0024
2025-02-11	2024-12-31	13F	NEOGENOMICS	COM NEW	64049M209	14,239,887	195,793	1.39	234,673	13.29	0.0041
2024-11-13	2024-09-30	13F	NEOGENOMICS	COM NEW	64049M209	14,044,094	-77,396	-0.55	207,150	5.76	0.0037
2024-08-13	2024-06-30	13F	NEOGENOMICS	COM NEW	64049M209	14,121,490	-89,529	-0.63	195,865	-12.32	0.0038
2024-05-10	2024-03-31	13F	NEOGENOMICS	COM NEW	64049M209	14,211,019	41,354	0.29	223,397	-2.56	0.0044
2024-03-11	2023-12-31	13F/A-1	NEOGENOMICS	COM NEW	64049M209	14,169,665	-146,536	-1.02	229,265	30.20	0.0050
2024-02-14	2023-12-31	13F	NEOGENOMICS	COM NEW	64049M209	14,169,665	-146,536		229,265		0.0044
2023-12-18	2023-09-30	13F/A-1	NEOGENOMICS	COM NEW	64049M209	14,316,201	-324,613	-2.22	176,089	-25.16	0.0043
2023-11-14	2023-09-30	13F	NEOGENOMICS	COM NEW	64049M209	14,316,201	-324,613		176,089		0.0008
2023-08-14	2023-06-30	13F	NEOGENOMICS	COM NEW	64049M209	14,640,814	770,257	5.55	235,278	-2.57	0.0056
2023-07-14	2023-03-31	13F/A-1	NEOGENOMICS	COM NEW	64049M209	13,870,557	195,812	1.43	241,486	91.12	0.0061
2023-05-15	2023-03-31	13F	NEOGENOMICS	COM NEW	64049M209	13,870,557	195,812		241,486		0.0062
2023-02-10	2022-12-31	13F	NEOGENOMICS	COM NEW	64049M209	13,674,745	500,037	3.80	126,355	11.39	0.0034
2022-11-14	2022-09-30	13F	NEOGENOMICS	COM NEW	64049M209	13,174,708	-141,693	-1.06	113,434	4.52	0.0033
2022-08-12	2022-06-30	13F	NEOGENOMICS	COM NEW	64049M209	13,316,401	345,898	2.67	108,530	-31.13	0.0031
2022-05-13	2022-03-31	13F	NEOGENOMICS	COM NEW	64049M209	12,970,503	113,534	0.88	157,592	-64.08	0.0037
2022-02-14	2021-12-31	13F	NEOGENOMICS	COM NEW	64049M209	12,856,969	186,607	1.47	438,680	-28.23	0.0100
2021-11-12	2021-09-30	13F	NEOGENOMICS	COM NEW	64049M209	12,670,362	472,802	3.88	611,218	10.94	0.0152
2021-08-13	2021-06-30	13F	NEOGENOMICS	COM NEW	64049M209	12,197,560	168,921	1.40	550,964	-5.03	0.0137
2021-05-14	2021-03-31	13F	NEOGENOMICS	COM NEW	64049M209	12,028,639	861,061	7.71	580,141	-3.51	0.0157
2021-02-12	2020-12-31	13F	NEOGENOMICS	COM NEW	64049M209	11,167,578	284,828	2.62	601,262	49.77	0.0174
2020-11-16	2020-09-30	13F	NEOGENOMICS	COM NEW	64049M209	10,882,750	-357,852	-3.18	401,465	15.29	0.0133
2020-08-14	2020-06-30	13F	NEOGENOMICS	COM NEW	64049M209	11,240,602	462,957	4.30	348,234	17.03	0.0124
2020-05-15	2020-03-31	13F	NEOGENOMICS	COM NEW	64049M209	10,777,645	264,642	2.52	297,571	-3.23	0.0127
2020-02-14	2019-12-31	13F	NEOGENOMICS	COM NEW	64049M209	10,513,003	81,178	0.78	307,506	54.17	0.0105
2019-11-14	2019-09-30	13F	NEOGENOMICS	COM NEW	64049M209	10,431,825	2,258,111	27.63	199,456	11.22	0.0074
2019-08-14	2019-06-30	13F	NEOGENOMICS	COM NEW	64049M209	8,173,714	2,401,227	41.60	179,331	51.84	0.0067
2019-05-15	2019-03-31	13F	NEOGENOMICS	COM NEW	64049M209	5,772,487	1,678,162	40.99	118,105	128.76	0.0046
2019-02-14	2018-12-31	13F	NEOGENOMICS	COM NEW	64049M209	4,094,325	254,684	6.63	51,629	-12.40	0.0023
2018-12-13	2018-09-30	13F/A-2	NEOGENOMICS	COM NEW	64049M209	3,839,641	743,245	24.00	58,939	45.19	0.0023
2018-11-23	2018-09-30	13F/A-1	NEOGENOMICS	COM NEW	64049M209	3,839,641	0		58,939		0.0023
2018-11-14	2018-09-30	13F	NEOGENOMICS	COM NEW	64049M209	3,839,641	743,245		58,939
2018-08-14	2018-06-30	13F	NEOGENOMICS	COM NEW	64049M209	3,096,396	36,581	1.20	40,593	62.58	0.0017
2018-05-15	2018-03-31	13F	NEOGENOMICS	COM NEW	64049M209	3,059,815	104,112	3.52	24,968	-4.65	0.0011
2018-02-14	2017-12-31	13F	NEOGENOMICS	COM NEW	64049M209	2,955,703	68,629	2.38	26,187	-18.50	0.0011
2017-11-14	2017-09-30	13F	NEOGENOMICS	COM NEW	64049M209	2,887,074	162,471	5.96	32,133	31.62	0.0015
2017-08-24	2017-06-30	13F/A-1	NEOGENOMICS	COM NEW	64049M209	2,724,603	44,820	1.67	24,413	15.46	0.0012
2017-08-11	2017-06-30	13F	NEOGENOMICS	COM NEW	64049M209	2,724,603	44,820		24,413
2017-05-12	2017-03-31	13F	NEOGENOMICS	COM NEW	64049M209	2,679,783	176,691	7.06	21,144	-1.43	0.0011
2017-02-14	2016-12-31	13F	NEOGENOMICS	COM NEW	64049M209	2,503,092	238,446	10.53	21,451	15.23	0.0012
2016-11-14	2016-09-30	13F	NEOGENOMICS	COM NEW	64049M209	2,264,646	134,133	6.30	18,616	8.67	0.0011
2016-08-10	2016-06-30	13F	NEOGENOMICS	COM NEW	64049M209	2,130,513	441,119	26.11	17,130	50.45	0.0011
2016-05-13	2016-03-31	13F	NEOGENOMICS	COM NEW	64049M209	1,689,394	93,298	5.85	11,386	-9.35	0.0007
2016-02-08	2015-12-31	13F	NEOGENOMICS	COM NEW	64049M209	1,596,096	23,602	1.50	12,561	39.40	0.0008
2015-11-12	2015-09-30	13F/A-1	NEOGENOMICS	COM NEW	64049M209	1,572,494	138,715	9.67	9,011	16.17	0.0004
2015-11-12	2015-09-30	13F/A-1	NEOGENOMICS	COM NEW	64049M209	1,572,494	138,715		9,011		0.0004
2015-08-13	2015-06-30	13F	NEOGENOMICS	COM NEW	64049M209	1,433,779	122,998	9.38	7,757	26.73	0.0005
2015-05-15	2015-03-31	13F/A-1	NEOGENOMICS	COM NEW	64049M209	1,310,781	115,997	9.71	6,121	22.86	0.0004
2015-05-14	2015-03-31	13F	NEOGENOMICS	COM NEW	64049M209	1,310,781			6,121
2015-02-12	2014-12-31	13F	NEOGENOMICS	COM NEW	64049M209	1,194,784	26,569	2.27	4,982	-18.14	0.0004
2014-11-12	2014-09-30	13F	NEOGENOMICS	COM NEW	64049M209	1,168,215	385,466	49.25	6,086	134.17	0.0005
2014-08-11	2014-06-30	13F	NEOGENOMICS	COM NEW	64049M209	782,749	-50,129	-6.02	2,599	-10.10	0.0002
2014-05-13	2014-03-31	13F	NEOGENOMICS	COM NEW	64049M209	832,878	150,085	21.98	2,891	16.95	0.0002
2014-02-12	2013-12-31	13F	NEOGENOMICS	COM NEW	64049M209	682,793	4,492	0.66	2,472	21.47	0.0002
2013-11-07	2013-09-30	13F	NEOGENOMICS	COM NEW	64049M209	678,301	288,652	74.08	2,035	31.21	0.0002
2013-08-13	2013-06-30	13F	NEOGENOMICS	COM NEW	64049M209	389,649	389,649		1,551		0.0002

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.